vs
FMC CORP(FMC)与SCANSOURCE, INC.(SCSC)财务数据对比。点击上方公司名可切换其他公司
FMC CORP的季度营收约是SCANSOURCE, INC.的1.4倍($1.1B vs $766.5M),SCANSOURCE, INC.净利率更高(2.2% vs -158.8%,领先161.0%),SCANSOURCE, INC.同比增速更快(2.5% vs -11.5%),FMC CORP自由现金流更多($631.1M vs $28.9M),过去两年FMC CORP的营收复合增速更高(8.6% vs 0.9%)
FMC公司是总部位于美国宾夕法尼亚州费城的化工制造企业,1883年创立之初以生产杀虫剂为主,后续逐步拓展业务至其他领域。二战期间曾为美国陆军部设计生产两栖履带登陆车,目前在全球拥有7000名员工,业务布局广泛。
ScanSource是全球领先的专业技术分销商,主营销售点系统、条码扫描设备、网络安全产品、云服务及通信解决方案,面向北美、拉美、欧洲的增值经销商、服务提供商及企业客户,覆盖零售、医疗、工业、公共部门等领域。
FMC vs SCSC — 直观对比
营收规模更大
FMC
是对方的1.4倍
$766.5M
营收增速更快
SCSC
高出14.1%
-11.5%
净利率更高
SCSC
高出161.0%
-158.8%
自由现金流更多
FMC
多$602.2M
$28.9M
两年增速更快
FMC
近两年复合增速
0.9%
损益表 — Q4 FY2025 vs Q2 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $1.1B | $766.5M |
| 净利润 | $-1.7B | $16.5M |
| 毛利率 | 39.8% | 13.4% |
| 营业利润率 | -130.8% | 2.3% |
| 净利率 | -158.8% | 2.2% |
| 营收同比 | -11.5% | 2.5% |
| 净利润同比 | -10457.1% | -3.3% |
| 每股收益(稀释后) | $-13.77 | $0.75 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
FMC
SCSC
| Q4 25 | $1.1B | $766.5M | ||
| Q3 25 | $542.2M | $739.6M | ||
| Q2 25 | $1.1B | $812.9M | ||
| Q1 25 | $791.4M | $704.8M | ||
| Q4 24 | $1.2B | $747.5M | ||
| Q3 24 | $1.1B | $775.6M | ||
| Q2 24 | $1.0B | $746.1M | ||
| Q1 24 | $918.0M | $752.6M |
净利润
FMC
SCSC
| Q4 25 | $-1.7B | $16.5M | ||
| Q3 25 | $-569.3M | $19.9M | ||
| Q2 25 | $66.7M | $20.1M | ||
| Q1 25 | $-15.5M | $17.4M | ||
| Q4 24 | $-16.3M | $17.1M | ||
| Q3 24 | $65.0M | $17.0M | ||
| Q2 24 | $295.1M | $16.1M | ||
| Q1 24 | $-2.7M | $12.8M |
毛利率
FMC
SCSC
| Q4 25 | 39.8% | 13.4% | ||
| Q3 25 | 23.8% | 14.5% | ||
| Q2 25 | 38.7% | 12.9% | ||
| Q1 25 | 40.0% | 14.2% | ||
| Q4 24 | 42.9% | 13.6% | ||
| Q3 24 | 36.3% | 13.1% | ||
| Q2 24 | 38.3% | 13.0% | ||
| Q1 24 | 37.0% | 12.6% |
营业利润率
FMC
SCSC
| Q4 25 | -130.8% | 2.3% | ||
| Q3 25 | -73.1% | 3.5% | ||
| Q2 25 | 12.0% | 3.3% | ||
| Q1 25 | 7.4% | 3.2% | ||
| Q4 24 | 19.2% | 2.5% | ||
| Q3 24 | 12.7% | 2.3% | ||
| Q2 24 | 6.0% | 2.9% | ||
| Q1 24 | 8.1% | 2.3% |
净利率
FMC
SCSC
| Q4 25 | -158.8% | 2.2% | ||
| Q3 25 | -105.0% | 2.7% | ||
| Q2 25 | 6.3% | 2.5% | ||
| Q1 25 | -2.0% | 2.5% | ||
| Q4 24 | -1.3% | 2.3% | ||
| Q3 24 | 6.1% | 2.2% | ||
| Q2 24 | 28.4% | 2.2% | ||
| Q1 24 | -0.3% | 1.7% |
每股收益(稀释后)
FMC
SCSC
| Q4 25 | $-13.77 | $0.75 | ||
| Q3 25 | $-4.52 | $0.89 | ||
| Q2 25 | $0.53 | $0.87 | ||
| Q1 25 | $-0.12 | $0.74 | ||
| Q4 24 | $-0.13 | $0.70 | ||
| Q3 24 | $0.52 | $0.69 | ||
| Q2 24 | $2.35 | $0.66 | ||
| Q1 24 | $-0.02 | $0.50 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | $584.5M | $83.5M |
| 总债务越低越好 | $3.4B | — |
| 股东权益账面价值 | $2.1B | $910.9M |
| 总资产 | $9.7B | $1.7B |
| 负债/权益比越低杠杆越低 | 1.62× | — |
8季度趋势,按日历期对齐
现金及短期投资
FMC
SCSC
| Q4 25 | $584.5M | $83.5M | ||
| Q3 25 | $497.7M | $124.9M | ||
| Q2 25 | $438.2M | $126.2M | ||
| Q1 25 | $315.3M | $146.3M | ||
| Q4 24 | $357.3M | $110.5M | ||
| Q3 24 | $416.7M | $145.0M | ||
| Q2 24 | $471.5M | $185.5M | ||
| Q1 24 | $417.8M | $159.1M |
总债务
FMC
SCSC
| Q4 25 | $3.4B | — | ||
| Q3 25 | $3.4B | — | ||
| Q2 25 | $3.4B | — | ||
| Q1 25 | $3.1B | — | ||
| Q4 24 | $3.1B | — | ||
| Q3 24 | $3.1B | — | ||
| Q2 24 | $3.1B | — | ||
| Q1 24 | $3.1B | — |
股东权益
FMC
SCSC
| Q4 25 | $2.1B | $910.9M | ||
| Q3 25 | $3.8B | $914.0M | ||
| Q2 25 | $4.4B | $906.4M | ||
| Q1 25 | $4.4B | $901.7M | ||
| Q4 24 | $4.5B | $900.7M | ||
| Q3 24 | $4.6B | $920.9M | ||
| Q2 24 | $4.6B | $924.3M | ||
| Q1 24 | $4.3B | $944.1M |
总资产
FMC
SCSC
| Q4 25 | $9.7B | $1.7B | ||
| Q3 25 | $12.1B | $1.7B | ||
| Q2 25 | $12.3B | $1.8B | ||
| Q1 25 | $11.8B | $1.7B | ||
| Q4 24 | $11.7B | $1.7B | ||
| Q3 24 | $12.2B | $1.8B | ||
| Q2 24 | $12.1B | $1.8B | ||
| Q1 24 | $12.0B | $1.8B |
负债/权益比
FMC
SCSC
| Q4 25 | 1.62× | — | ||
| Q3 25 | 0.89× | — | ||
| Q2 25 | 0.76× | — | ||
| Q1 25 | 0.71× | — | ||
| Q4 24 | 0.69× | — | ||
| Q3 24 | 0.68× | — | ||
| Q2 24 | 0.68× | — | ||
| Q1 24 | 0.72× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | $657.1M | $30.8M |
| 自由现金流经营现金流 - 资本支出 | $631.1M | $28.9M |
| 自由现金流率自由现金流/营收 | 58.3% | 3.8% |
| 资本支出强度资本支出/营收 | 2.4% | 0.3% |
| 现金转化率经营现金流/净利润 | — | 1.87× |
| 过去12个月自由现金流最近4个季度 | $-102.5M | — |
8季度趋势,按日历期对齐
经营现金流
FMC
SCSC
| Q4 25 | $657.1M | $30.8M | ||
| Q3 25 | $-184.2M | $23.2M | ||
| Q2 25 | $65.9M | — | ||
| Q1 25 | $-545.0M | $66.1M | ||
| Q4 24 | $427.9M | $-6.2M | ||
| Q3 24 | $159.5M | $44.8M | ||
| Q2 24 | $292.2M | — | ||
| Q1 24 | $-142.9M | $160.2M |
自由现金流
FMC
SCSC
| Q4 25 | $631.1M | $28.9M | ||
| Q3 25 | $-207.9M | $20.8M | ||
| Q2 25 | $50.9M | — | ||
| Q1 25 | $-576.6M | $64.6M | ||
| Q4 24 | $406.3M | $-8.2M | ||
| Q3 24 | $143.8M | $42.5M | ||
| Q2 24 | $282.3M | — | ||
| Q1 24 | $-163.6M | $157.7M |
自由现金流率
FMC
SCSC
| Q4 25 | 58.3% | 3.8% | ||
| Q3 25 | -38.3% | 2.8% | ||
| Q2 25 | 4.8% | — | ||
| Q1 25 | -72.9% | 9.2% | ||
| Q4 24 | 33.2% | -1.1% | ||
| Q3 24 | 13.5% | 5.5% | ||
| Q2 24 | 27.2% | — | ||
| Q1 24 | -17.8% | 21.0% |
资本支出强度
FMC
SCSC
| Q4 25 | 2.4% | 0.3% | ||
| Q3 25 | 4.4% | 0.3% | ||
| Q2 25 | 1.4% | 0.3% | ||
| Q1 25 | 4.0% | 0.2% | ||
| Q4 24 | 1.8% | 0.3% | ||
| Q3 24 | 1.5% | 0.3% | ||
| Q2 24 | 1.0% | 0.2% | ||
| Q1 24 | 2.3% | 0.3% |
现金转化率
FMC
SCSC
| Q4 25 | — | 1.87× | ||
| Q3 25 | — | 1.17× | ||
| Q2 25 | 0.99× | — | ||
| Q1 25 | — | 3.79× | ||
| Q4 24 | — | -0.36× | ||
| Q3 24 | 2.45× | 2.64× | ||
| Q2 24 | 0.99× | — | ||
| Q1 24 | — | 12.51× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
FMC
| Insecticides | $440.3M | 41% |
| Herbicides | $378.8M | 35% |
| Fungicides | $140.4M | 13% |
| Plant Health | $65.6M | 6% |
| Other | $45.0M | 4% |
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |